Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001044321-09-000247
Filing Date
2009-12-22
Accepted
2009-12-22 11:23:53
Documents
1
Period of Report
2009-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4134
  Complete submission text file 0001044321-09-000247.txt   6117
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33509 | Film No.: 091254137

Mailing Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033
Business Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033 (323) 224-3900
RESPONSE GENETICS INC (Issuer) CIK: 0001124608 (see all company filings)

EIN.: 000000000
SIC: 2835 In Vitro & In Vivo Diagnostic Substances